Thromboembolic risks of recombinant factor VIIa Use in warfarin-associated intracranial hemorrhage: a case–control study

Thromboembolic risks of recombinant factor VIIa Use in warfarin-associated intracranial hemorrhage: a case–control study

<p>Abstract</p> <p>Background</p> <p>Recombinant factor VIIa (rFVIIa) may be used for rapid hemostasis in life-threatening hemorrhage. In warfarin-associated intracerebral hemorrhage (wICH), FVIIa use is controversial and may carry significant thromboembolic risks. We c...

Full description

Bibliographic Details
Main Authors: H-Y Chou Sherry, Xuemei Cai, G Konigsberg Rachael, M Bresette Linda, V Henderson Galen, A Sorond Farzaneh, K Feske Steven
Format: Article
Language:English
Published: BMC 2012-12-01
Series:BMC Neurology
Subjects:
Activated recombinant factor VII
Intracerebral hemorrhage
Thromboembolism
Warfarin
Online Access:http://www.biomedcentral.com/1471-2377/12/158

Internet

http://www.biomedcentral.com/1471-2377/12/158

Similar Items